TY*, Harvard Medical School, Boston, Mass. The health of 750 low-income families has been studied by an experiment in which families were randomly assigned to either an experimental or one of two control groups. Experimental families received comprehensive pediatric care for three years, while controls received usual fragmented care. Data were collected before, during and after the care period by home interviews, diaries and record reviews. Analysis of data obtained by interviews and diaries from experimental families and one control group indicate that the experimental families had significantly fewer hospitalizations, fewer operations, more total physician visits, more physician visits for health supervision, and fewer physician visits for illness. As perceived by the mother, there were more episodes of serious illness in the control families. There were no differences in recorded upper respiratory symptoms, although there were fewer recorded lower respiratory episodes in the experimental families. These data indicate measurable differences between families who receive comprehensive care and those who do not. J. ALPERT: The difference was that health care was delivered to the experimental group by a team of physician, public health nurse, and social worker. The physician was a fellow in the Family Health Care Program and thus similar in experience to the majority of thirdyear residents in our training programs. The minimum of time during which this physician would deliver care was one year, and it could be as long as two years.
We assume that the care offered to the experimental families was technically comparable with the controls and thus the major difference in the groups would be the fact that continuity was being delivered to the experimental families, compared with the episodic nature of the care in the control families.
D. RUSH (University of Rochester): You did not mention anything about non-cooperators.
J. ALPERT: There are, of course, drop-outs at almost every point in this study, beginning with the initial offer of participation in the health survey, when there * By invitation were approximately 1 percent refusals. The total dropout rate, once the sample had been selected, was 24 percent, most of these due to moving away. However, some of these families undoubtedly are the non-cooperators. The data we have will enable us to describe these families and to estimate how this loss affected the outcome.
There is within the experimental group an important number of non-cooperators; that is, families who initially refused the offer of the comprehensive care. These families have become the subject of a special study.
We are aware of the problem, and I would hope that we will be able to answer it very satisfactorily by the time the analysis is done.
E. SIEGEL (University of North Carolina): Can you discuss for us any attempts to test the reliability or validity of the data collected by the health diaries? Similarly, the household interview schedules? J. ALPERT: It is very difficult to know about validity in the health diaries, because there is no way that we can ascertain the validity of this information. We know at this point, however, that there is much more information in the health diaries than, for example, in the hospital record reviews. It is possible that information and material were omitted from the health diaries; but if the families were leaving this information out, they certainly have given us an extraordinary wealth of information to deal with. One way in which we will test validity is by attempting to compare instruments. Here we have the problem that they may not be measuring the same thing. As far as the reliability of the diary and interviews is concerned, we will look at internal consistency. We have reported in the Journal of Social Science and Medicine a report of the early reliability of these instruments. (KOSA, J.; ALPERT, J. and HAG-GERTY, R.: On the reliability of family health information. Soc.Sci. Med. 1: 165-181 [1967] .)
The methodology of this study requires careful evaluation of the reliability and validity of these instruments, and we are working with this. At this point I can only say for the data presented and within the model, errors in reliability should have been distributed equally between groups.
F.J. DE CASTRO (Wayne County General Hospital, Eloise, Mich.): Have you attempted to measure consumer satisfaction? Do you think this is an important parameter in this kind of study?
J. ALPERT: Yes, I do. We have a number of measures of consumer satisfaction within the experimental group. Presented with the theoretical problem as to how they would behave should neighborhood health centers be opened in their area, they indicated that they would continue with their present care; whereas the control families indicated that at least for health supervision they would go to the neighborhood health center, although for illness they probably would continue to go to the hospital. Moreover, the experimental families break very few appointments, although we do not know for sure whether this represents satisfaction or the loss of non-cooperators referred to earlier.
J. METCOFF (Michael Reese Hospital, Chicago): Could you clarify the role of the physician in relation to his functions for the experimental and control groups ?
Secondly, could you tell us whether any attempt was made to evaluate the physician's response in these two circumstances?
J. ALPERT : I am going to answer your first part by saying that the function of the physician for the experimental families would be very similar, if not identical, to the function of the physician in private group or partnership practice.
There were at any one time three physicians delivering care, with one nurse and one social worker. The physicians had made house calls, and provided twentyfour hour, seven-day-a-week coverage. The control families, who had no contact with these physicians, received care largely from physicians staffing the center city institutions.
In evaluating the attitudes of our fellows and equivalent house staff in the community, we have some data that document that the attitudes of the physicians are very important in the delivery of this care. These data present at the moment more problems than solutions and document many negative attitudes towards disadvantaged families. The physicians for the experimental families had many opportunities to openly discuss these feelings.
We certainly are looking very carefully at the quality of the care that is delivered, both by way of a timemotion study in the experimental and control families, as well as a before and after interview of the attitudes of the physicians towards the delivery of this care. S.A.DOXIADIS (Aghia Sophia Children's Hospital, Athens, Greece): Are you trying to assess and measure also morbidity in the psychological field; that is, behavior problems? J. ALPERT: Yes.
H. MEDOVY (Children's Hospital, Winnipeg): Were there drop-outs among the health personnel involved in delivering care, in view of the reports from some centers that there has been disenchantment on the part of medical and nursing personnel assigned to this type of project? J. ALPERT: Our population of nurses, social workers, and physicians was very stable. The period during which the physicians are associated with the program is limited to that period during which he is delivering care. The physician is engaged in other activities as part of a learning experience in health care delivery. This question emphasizes the extraordinary importance of describing the service that is delivered so that others may interpret what factors contributed to whatever differences might be found. In a cohort of some 17,000 children born between 1960 and 1966 were 367 children who experienced a convulsive disorder. The children receive comprehensive medical care in the Kaiser Permanente Health Plan facilities and are followed longitudinally by the Child Health and Development Studies (CHDS). The purpose of the present investigation is to correlate the incidence of convulsive disorders with certain characteristics and factors in mother and child. Of the 367 children, 247 experienced febrile convulsions only. The remaining 120 children developed a nonfebrile convulsive disorder. The distribution by age of first seizure was different for the febrile and the nonfebrile group. The latter varied little by age; those of the febrile group exhibited a peak at the second year of life. At the end of the fifth year, about 2 % of the cohort had had one or more febrile convulsions, and 1 % had had one or more nonfebrile seizures. Nine percent of those with febrile convulsions, but nearly one-third of the nonfebrile group, had one or more severe congenital anomalies. There was a considerable excess of boys in the nonfebrile group (62 %). The children with febrile convulsions were distributed by birthweight and gestational age as were children without convulsions. The nonfebrile group had an excess of children with birthweights of 1500-2500 g, especially of those who were of 37 weeks or longer gestation (8.1% compared to 2.3 %). The interval between the termination of the preceding pregnancy and the beginning of the pregnancy that terminated with a 'convulsive disorder' child was very short for the nonfebrile group (53 % less than 12 months), while the interval for the febrile group did not differ from the group without a convulsive disorder (38 % less than 12 months). Discussion K.W. DUMARS (University of California, Los Angeles) : Are you including the problem of the static birth injury occurring particularly in the premature child as a congenital malformation?
In your tabulation of congenital malformations are you speaking just of congenital malformations of the central nervous system, or any organ system ? B.J. VAN DEN BERG: We evaluated the records of all the children for congenital anomalies of all systems. These included anatomical and functional congenital anomalies that were diagnosed at birth or later.
The congenital anomalies are divided according to their significance in 'severe' and 'moderate'. The trivial anomalies, such as skin tags, etc., are not included in this study. Congenital anomalies originate from hereditary factors or from environmental factors during pregnancy or birth process. So central nervous system disorders probably associated with traumatic factors at birth are included as a congenital anomaly.
E. H. SOBEL (Albert Einstein College of Medicine, New York): I wonder if you could tell us the incidence of treatable metabolic abnormalities among the children with nonfebrile seizures; your slide showed that additional diagnostic procedures were done in 14 percent of that group. I am wondering about hypocalcemia, hypoglycemia, and such abnormalities.
B.J. VAN DEN BERG : For this presentation we divided the convulsive disorders in two main groups; namely the febrile and the nonfebrile. Among the nonfebrile are also convulsions which have a metabolic origin. The group of the nonfebrile convulsions is not an etiologically homogeneous group. Nine of the 113 children with nonfebrile convulsions had abnormal values of blood chemistry. This does not mean, however, that the convulsion was a direct effect of those deviations.
B. G. LEVENTHAL (National Institutes of Health, Bethesda): How many of the children with febrile seizures had more than one febrile seizure, and how many of them had a family history of convulsive disorders?
B.J. VAN DEN BERG: Of the children with febrile convulsions, 30 percent had one or more repetitions and there were three pairs of sibs.
A.YANKAUER (Massachusetts General Hospital): May not the incidence of convulsions be rather strongly influenced by the perception of the mother and the consultation with the physician? And would it not, therefore, be more reliable to relate such factors as socioeconomic status and prenatal experiences only to those children who had more than one convulsion? B.J. VAN DEN BERG : I think it is inherent in febrile convulsions that often they are only single episodes. The reason that we still included them is that we have a feeling that the validity of the information that the mother gave soon after the convulsion is pretty high. I agree with you that the mothers do not know all the time what a convulsion is, but if they came to a pediatrician soon after the convulsion, and their information is evaluated by him shortly after the convulsion happened, we felt that we should include these single episodes. In our analysis, however, we separate the children with only one episode from those with multiple episodes.
A.YANKAUER: But the point is that there may be many more mothers who do not consult the pediatrician for one single convulsion and the bias is a socioeconomic one.
B.J. VAN DEN BERG: I think there might be those cases too, but as the study relates to a prepaid medical plan, we feel that perhaps for such a rather disturbing thing as a convulsion most mothers will go to ask advice of the pediatrician. But, of course, our study relates only to cases for which medical attention was sought.
J.J.Ross (University of Florida College of Medicine): I understand that this was a study of seven years, but what is the range and mean of this period? About the electroencephalograms, what were the abnormalities described in the two groups? Were there any twins in this study, and what did the twins have? B.J. VAN DEN BERG : We did not include twins in this study. The incidence among twins was not much different from that of singletons, but to make the group more uniform we included only singletons.
Different types of electroenecephalographic abnormalities are found, of course. Among the nonfebrile group are five children with the picture of hypsarhythmia and two with typical petit mal tracings of 3 per second spike and dome forms. Then there was a variety of abnormalities in frequency, shape and voltage.
The follow-up of the children is very different in length, because the children are born in the period from 1960 to 1967, so the youngest children are not even one year old, and the oldest children are in their eighth year.
Our data relate for each age group to the number of children that were at risk during that age period.
Our child health and development study has an extensive follow-up department, and we try to follow all the children, even when they go to remote places. We keep in touch with almost all of the mothers by means of questionnaires. But in this study on convulsions we included only the information of the Kaiser clinics.
T. E. CONE (Children's Hospital, Boston): Was there a sex difference in the incidence of the convulsions and if there was a difference in males over females, was it larger in the febrile versus the nonfebrile seizures? B.J. VAN DEN BERG: We found that in the febrile group the number of males and females was about equal. There were slightly more males, similar to the proportion in the general population. However, in the nonfebrile group, 60 percent of the children were male, and 40 percent were female. Complete right and left heart catheterizations with cineangiography were normal.Tiny left to right shunts were excluded with right sided ascorbic acid dye dilution curves sampling with a platinum catheter in the pulmonary artery after both pulmonary artery and left ventricular injection. Intracavitary electrocardiography in the right side in all was normal. Intracavitary phonocardiography in the right side was also normal, though done only in three children. On the left side it was done in all, and demonstrated the early diastolic murmur to be present only within the left ventricle in 7 and to be louder in the left ventricle than the root of the aorta in 2. The murmur was not decrescendo, but diamond shaped, though limited only to the first third of diastole. Cineangiography from the root of the aorta demonstrated normal coronary arteries, no aortic regurgitation and 3 aortic cusps. The etiology of the diastolic murmur is not known, but the timing, location and character of the murmur suggest, since it occurs during the peak period of coronary blood flow, that it could represent normal coronary artery flow.
Discussion
A. J. Moss (University of California, Los Angeles): That these murmurs were heard best with the children lying down would lead me to suspect that they might be related to increased cardiac output. Were cardiac output studies done on these children? J.LIEBMAN: If you mean were the cardiac outputs measured by a dye dilution technique or measured oxygen consumption, the answer is no. The outputs were measured using assumed oxygen consumptions and were normal. That is a very good point, however. Except for two, the hearts of the children were not particularly hyperdynamic and the children did not have wide pulse pressures. We did not suspect clinically any reason for high cardiac output, but it would have been a very good thing to accurately measure.
W.F.FRIEDMAN (National Heart Institute, Bethesda): What is the influence of exercise and the phases of the respiratory cycle on these murmurs? J.LIEBMAN: With respiration usually there was no change. Occasionally the murmurs became louder on expiration, which again points to the murmurs being left sided. With exercise, in order to exercise the children properly, you have to have them standing up. When you have them standing up, most of the time the murmurs go away. We did exercise many on the outside a number of times, but not in the cath lab. After we exercised the children and had them lie down, the murmur was usually louder, just as the systolic murmurs were.
A. M. RUDOLPH (University of California, San Francisco Medical Center): I wonder why you are so ready to exclude the possibility that this is a rapid inflow phase murmur. It seems to appear exactly at the point of rapid inflow.
I would be reluctant to exclude this possibility merely on the basis of frequency, because although we are inclined to believe that all diastolic murmurs originating from the mitral valve have low frequencies, this is usually related to the fact that the valve is abnormal. I wonder, though, if the valve is normal, whether one may not find a higher frequency murmur.
In fact, I did not get the impression that the murmurs were of very low frequency.
I would also like to ask whether you studied the effects of isoproterenol on the murmurs in these patients.
J. LIEBMAN : No, we did not study the effect of isoproterenol on the murmurs, because we could only have one catheter in at a time, and we had a pressure catheter in when we were studying the effect of isoproterenol, to see whether the gradient would become larger. You would need a double lumen catheter, which is a size eight phonocatheter, which I did not want to use in young children. The phonocatheter was put in separately.
In answer to the first question, obviously we do not know the cause of the diastolic murmurs. DAN SILBERT also thinks that these murmurs are flow murmurs through the mitral valve. However, as you recall, while the phonocatheter is in the heart, we can listen to the intracavitary murmur while it is being recorded. Unquestionably, the murmurs were of high frequency. sicians and Surgeons, Columbia Univ., New York, N.Y. Because infusion of alkali during asphyxia prolongs survival and lessens brain damage in newborn rhesus monkeys, rapid correction of pH has been considered a desirable adjunct in resuscitation of the asphyxiated human infant. This practice is not without hazard. To evaluate the potential adverse effects of this treatment, 47 newborn piglets were asphyxiated to either the last gasp (Group I) or to cardiac arrest (Group II). THAM or sodium bicarbonate (equal volume of 0.3 M solutions; both pH 8.6) or an equal volume of a control solution, was given rapidly into the umbilical vein or aorta at the end of asphyxia and the animals ventilated. Blood pressure, heart rate and ECG were monitored throughout.
Route of infusion prejudiced survival only in Group II. ECG abnormalities followed aortic infusion. They were present transiently in 2/3 of Group I but persisted in all of Group II, the most severe changes being asystole, A-V dissociation and occasionally ventricular fibrillation, which were invariably fatal. Such abnormalities occurred with both alkali and control solutions. All animals of Group II receiving alkali into the umbilical vein lived, and no change in liver parenchyma was detected. Alkali shortened the time interval to first gasp and to onset of spontaneous respiration. It was not necessary for survival in Group I but was essential in Group II. The effect upon pH correction was similar with both alkalis. With sodium bicarbonate, Pco 2 and serum sodium were both increased at 3 minutes and sodium was still elevated at 1 hour; osmolality was higher in animals receiving THAM. While infusion of alkali following asphyxia will expedite recovery, it may be hazardous and even fatal if administered too rapidly in the presence of a severly impaired circulation.
A.Y. SWEET (Cleveland Metropolitan General Hospital) : The last slide that you showed implies that there was rather severe damage to the liver after infusion. Having talked to your pathologist, I wonder if you could present some information about surviving animals some time distant from when they were infused. S. G. HAWORTH : We do not have any information on liver damage following long-term survival, since the animals were only kept alive for a few hours. As I have mentioned, only 2 of the animals showed small areas of necrosis and 2 had subcapsular hemorrhages. The latter findings were probably caused by the prolonged cardiac massage which was necessary.
In the earlier work on monkeys, hemorrhagic necrosis was observed but the solutions used for correction of acid-base was strongly alkaline (pH 11.0) and hypertonic. Despite this damage the clinical course of these animals differed little from their controls. Examination of the livers after some months of survival showed almost complete regeneration with minimal scarring.
S. SEGAL (University of British Columbia, Vancouver) : Many who correct rapidly with sodium bicarbonate use half the volume, i.e., twice the concentration of solution compared with yours, taking about 10 minutes or more for the infusion. Did you carry out any other studies which might rule out or at least minimize the effect of a sudden and large increase of intravascular volume, to separate that effect from that of the rapid introduction of the buffer itself?
It seems to me we should be more specific when we talk about rapid correction-how rapid-and I think perhaps we have to be more specific about how much volume we are introducing. It is possible that much of the effect, as I think you intimated, may have been produced by an overwhelming increase in volume, rather than by the rapid correction of pH.
S. G. HAWORTH : Yes, the abnormalities appeared to be related to the sudden increase in volume. Electrocardiographic abnormalities were seen with both alkali and control solution. The average infusion time was only 60 seconds, considerably shorter than would be the case in treating human infants. Furthermore, the infusion was given before artificial ventilation or cardiac massage. In clinical practice we would advocate that the infant be first well ventilated and his circulation supported by cardiac massage before administra-tion of alkali. The alkali should be administered relatively slowly-probably at no faster rate than 5 ml/min. Ideally, the electrocardiograph should be monitored throughout the procedure. Our experiments show that the administration of alkali into either umbilical artery or vein is not without hazard. At the present time, we do not have information to indicate the benefit of one route over the other if ventilation or cardiac massage is instituted before infusion.
J.WASHINGTON (Louisiana State University School of Medicine and Tulane Medical School): I do not see any mention about body temperature in these animals. Was body temperature controlled in a certain way, or were any observations made in case there was no control?
S.G. HAWORTH: Body temperature fell 3°C during asphyxia and resuscitation and then returned to normal over the next hour in the warm environment of the incubator.
M. STAHLMAN (Vanderbilt University School of Medicine, Nashville): Would you comment further on the potential etiology of your cardiovascular changes that followed rapid infusion.
We have seen clinically acute pulmonary edema. Where you have had severe asphyxia with constriction of the pulmonary arteries, with rapid infusion of alkali, acute pulmonary edema can quite rapidly result in a few instances.
In the cases where this was infused into the aorta, do you have serial measurements of lactic acid produced? With asphyxia there is a shutting down of the peripheral circulation and the rapid reopening of this circulation during the infusion time may flood the circulation. Then, with very high levels of lactic acid, this might account for your cardiovascular changes.
S. G. HAWORTH : We did not measure lactic acid levels. However, the electrocardiographic changes occurred within 20 or 30 seconds of starting the infusion. This would be too short an interval for mobilization of the lactate from areas that had been poorly perfused, particularly in those experiments when the circulation was collapsed.
With regard to etiology, we initially considered that coronary perfusion with the alkaline solution might be the cause, but this seems unlikely since the changes were also observed with the control solution. A reflex response from vascular distension is also a possibility. Other investigators, using non-asphyxiated dogs, have observed ECG changes and hypotension with rapid infusion into both right and left sides of the heart. Section of the vagi modified the hypotensive response seen with the infusion into the left heart. A further possibility is the temperature of the solution. In our experiments it was 25° (room temperature). We plan to investigate this factor by infusion solution at normal body temperature.
M. DELIVORIA (Graduate School of Medicine, University of Pennsylvania): Were you monitoring the oxygen tension during the rapid correction with alkali after the asphyxia? S. G. HAWORTH : Arterial oxygen tensionwas followed serially in some animals. However, due to variability in response to resuscitation, the scatter of values for oxygen tension was large, and it was not possible to show a significant difference between those receiving alkali and control animals.
A.M.RUDOLPH (University of California, San Francisco Medical Center): I noticed in one of your tracings that there was a marked T wave change. Could the effect you describe on the heart be due to thehypertonic sodium levels in the solutions injected? We know that hypertonic sodium solutions can affect myocardial function, probably by causing aggregation of red cells.
S. G. HAWORTH : It was certainly seen following the aortic injections, but it was seen with equal frequency when control solution was infused. This contained 145 mEq/1 of sodium.
J when THAM, sodium carbonate or sodium bicarbonate were infused during the course of asphyxia. THAM and sodium carbonate were equally effective with regard to correction of pH prior to ventilation, while sodium bicarbonate was much less effective. In the present experiments we did not examine the acid-base changes following alkali infusion prior to the onset of ventilation. Sodium bicarbonate appeared to be a more effective buffer as judged by the values 3 minutes after cessation of asphyxia. We have related this, in part, to the pK. of the solution; for sodium bicarbonate it is 6.1 and for THAM 7.4 or higher, but this latter depends on the temperature. This would make sodium bicarbonate a more effective buffer at the pH range encountered in severe asphyxia. Furthermore, although the solutions we used were equimolar and the same pH, they were not equal in buffering capacity, sodium bicarbonate exceeding THAM by 6 mEq/1. These particular factors are probably more important than any species differences which might exist. Incidentally, the THAM was titrated with hydrochloric acid in both the monkey and the present experiments.
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Patterns of Micturition in Normal and Enure tic Children. M. ESPERANCA* and J.W. GERRARD, Department of Paediatrics, University of Saskatchewan, Saskatoon, Canada. The frequency with which normal children pass urine and the volume of urine passed over 4 days were studied in 310 normal children aged 3-15 years, and in 50 enuretics aged 4-14 years. The bladder capacities were also measured (1) after a loading dose (480 ml) of water and (2) by measuring every specimen of urine passed over a 4-day period in normals, and a 7-day period in enuretics.
The average bladder capacities of normals are 382-975 ml per m 2 , and of enuretics 198-355 ml per m 2 , capacities increasing with age.
The enuretics, because their bladders are small, pass urine nearly twice as frequently as normals. The small bladder size is, in the majority of instances, reversible by Imipramine. In 30 enuretics treated in this way, 10 were improved and 17 cured. In those cured, bladder capacities increased from 198-381 per m 2 to 372-639 per m 2 , i. e., normalized, and urinary frequency diminished correspondingly. The term nocturnal enuresis, though correct in so far as it goes, is a misnomer, for the prime problem is a bladder which is small because it is in spasm, and which usually relaxes under the influence of Imipramine.
Discussion
Dr. GARROW (LOS Angeles): What is the incidence of enuresis in males and females in your study group, and were there any differences at all between males and females in your findings?
Secondly, did you have an opportunity to study bladder capacity changes in normals as a result of their receiving Imipramine? M. ESPERANCA: We did not give Imipramine to normal children.
In our group of fifty enuretic children, forty-one were boys and nine were girls. The improvement, or nonimprovement was similar in both sexes.
B. STARFIELD (Johns Hopkins University School of Medicine, Baltimore): I wonder how you managed to collect every urine specimen on the children. Were they hospitalized?
How long did it take before you gained an effect from the Imipramine?
M. ESPERANCA : They were normal children. No one was in hospital.
We managed to collect every specimen, putting somebody inside of the washroom, and closing all washrooms in the school except one. We had some men for the boys, and some nurses for the girls.
All the children were taking Imipramine. The first night they took Imipramine, they became dry.
B. M. KORSCH (Children's Hospital, Los Angeles): How long have you followed these children, and what is your relapse rate? Have you any clues as to whether your total study situation and interest in these children might have had an effect? M. ESPERANCA: We have followed these children for about six months. For the ones who are cured, or completely controlled, after medication is stopped after 2 weeks, about 20 percent relapse. Then you give them a Imipramine for one month, and in this group about 10 % relapse again. F.A. OSKI (University of Pennsylvania School of Medicine) : Could you tell me how this method of using drugs or diets compares with the simpler Muellner method of just encouraging fluids and asking the child to withhold urination? R. H. HELLER (Kirk Army Hospital, Aberdeen, Proving Grounds): Did you get equally gratifying results in children who had been enuretic all their lives, as opposed to those who had a recent onset of enuresis?
M. ESPERANCA : All of these children were primary enuretics-functional.
H. L. HODES (Mount Sinai School of Medicine, New York): Imipramine is a dangerous drug if it is given in too large a dose. We had a child who was brought into our hospital who died of an overdose of this drug. The child suffered from cardiac damage with irreversible arrhythmia. I did not see this child myself, but Dr.
BONFORTE, who is here, did. R.J. BONFORTE (Mount Sinai School of Medicine, New York): The child was a 2 ^-year-old boy who had taken approximately twenty 25 mg tablets of Imipramine.
In a survey of the world literature, we found several case reports of poisoning with this drug. Even dosages of 75 to 100 mg have caused severe myocardial toxicity in small children. Were any electrocardiographic changes or clinically detected arrhythmias noted in your patients? M.ESPERANCA: We never did an EKG in our children. We had no complications except one-dermatitis. R.J.BONFORTE: What dosage of Imipramine did you use?
M.ESPERANCA: Below five years it was 25 mg; from five to ten, 50 mg, 25 mg b.i.d.; and after ten, 75 mg, 25 t.i.d. R.J. BONFORTE : I think the point that Dr. HODES raises should be reemphasized. Imipramine apparently is not a benign drug and the availability of this agent around households is a potentially lethal weapon. I think that if this drug is to be encouraged for use in treatment of enuresis, its toxicity should be taken into consideration.
F.J. DE CASTRO (Wayne County General Hospital, Eloise, Mich.): We have been using Pro-Banthine with a fair amount of success, and it seems that Imipramine acts as a partial paralytic drug.
M.ESPERANCA: I used Pro-Banthine in another group of enuretics not included in this study, and there was about 10 percent improvement. Surprisingly, their growth rates temporarily increased above normal for 1.5-2.5 years and then continued at normal rates along higher percentiles for 1-4 additional years. Current concepts of the neuroendocrine regulation of linear growth in children fail to account for this phenomenon. A 9-year-old boy developed permanent diabetes insipidus (DI), secondary hypothyroidism and hypoadrenalism, and had low serum growth hormone which failed to increase after insulin or arginine stimulation. While on therapy with pitressin only, he grew 4.7 inches over 1.5 years increasing from the 3rd to the 50th percentile. Excessive weight gain occurred concomitantly. His serum insulin response to arginine was excessive (173 /AJ/ml) and its protein anabolic action may account for his growth spurt. Two girls, with permanent DI, secondary hypothyroidism and hypoadrenalism following craniopharyngioma removal increased their height percentiles from 10th to 50th, and 5th to 25th respectively. Their weight gain was also excessive. One developed acromegatic features associated with low growth hormone and elevated prolactin levels. Synergism between chorionic growth-hormone-prolactin and growth hormone has been demonstrated experimentally (Endocrinology 78: 707 [1966] ). It is possible that in our patient the high level of prolactin acted synergistically with growth hormone to produce a growth spurt. 'Catch up' growth following interruption of hypothalamic-pituitary pathways is not rare in our experience (3 cases in 5 years). Elucidation of its etiology could increase our understanding of normal growth processes and facilitate treatment of hypopituitarism.

S. D. FRASIER (LOS Angeles City General Hospital):
Our experience validates that of Dr. KENNY'S. We have seen two patients with clinical courses similar to those presented here. The laboratory evaluation has been completed in one of them, and our findings are somewhat different than Dr. KENNY'S. Our patient showed detectable levels of growth hormone following surgery, which included stalk section, and failed to show any rise in the serum concentration of growth hormone with insulin induced hypoglycemia.
These observations would suggest that the acute changes in serum growth hormone levels observed with hypoglycemia, arginine, pyrogen or vasopressin may not be related to the growth-promoting activity of growth hormone. It would be of interest to evaluate the diurnal variation in serum growth hormone concentration in these patients. This might be better correlated with promotion of linear growth. Specifically, what I have in mind is the fact that we have studied recently two groups of grossly obese children, one group growing above the 95th percentile for height, and the other growing below the 3rd percentile for height. Neither of these groups has growth hormone levels that one would consider normal. They are both subnormally low. Both of these groups have insulin levels that are excessively high.
It would, therefore, appear that all kinds of problems exist in interpreting growth data, if we merely use the acute responses to either insulin or arginine.
F. M. KENNY : Your data might be considered to confirm our hypothesis that in obesity, insulin is acting either alone, or in synergism with low levels of growth hormone or with prolactin, as a growth promoting hormone.
M. M. GRUMBACH (University of California, San
Francisco Medical Center): This paper raises a great many questions, some of which have been alluded to by the previous discussants.
One of the suggestions that Dr. KENNY considered aside from the role of hyperinsulinism is the question of a nonimmunoreactive product coming from, presumably, the hypothalamic pituitary axis perhaps even elsewhere.
We have recently become aware of the reverse: an immunoreactive but biologically relatively non-potent growth hormone.
I wonder if Dr. KENNY might speculate what the source of this material might be. The question of whether or not the human pituitary secretes or produces a separate prolactin, as is true of many of the lower species of mammals, is still moot.
F. M. KENNY: In our patients, no attempt was made to remove the pituitary gland at the time of craniopharyngioma removal. Therefore, the pituitary, deprived of the usual connection with the hypothalamus by stalk section, could be the source of prolactin.
Three lines of evidence favor the existence of prolactin in the human being:
(1) In cultures of human pituitary cells a rapid decrease in growth hormone activity with a concomitant increase in prolactin activity was observed (PASTEELS, J.L. etal.: C. R. Acad. Sci. 256: 2031 Sci. 256: [1963 ).
(2) Human prolactin activity can be partially separated from that of growth hormone by chroma tography (CHEN, H. C. and WILHELMI, A. E.: Proc. 46th Meeting of the Endocrine Society, June 18-20, 1964, p.80) .
(3) Galactorrhea observed in the Chiari-Fromel syndrome, and with some pituitary tumors was shown to be associated with high levels of prolactin demonstrated by the pigeon crop assay (CANFIELD, C.J. and BATES, R.W.: New Engl.J. Med. 273: 897 [1965] ).
In these patients with galactorrhea there had been no clinical evidence of growth hormone excess to suggest that the apparently elevated level of prolactin on bioassay was actually due to growth hormone. D. B. CHEEK (Johns Hopkins Hospital): It is perhaps not fully appreciated that insulin is always necessary for growth to occur. Growth hormone is ineffective if insulin is lacking as shown by GAEBLER et al. (Amer. J. Physiol. 187: 357 [1956] ) and by MILMAN etal. (Amer. J.Physiol. 166: 354 [1951] ). Thus these two hormones work together and I would suggest that growth hormone is more important to cell number increase while insulin is more closely related to cell size increase and protein synthesis. Indeed with respect to data I shall be presenting, one might conclude that protein synthesis in the liver is initiated by insulin and that the presence of growth hormone is not mandatory. The same remarks pertain to skeletal collagen. Thus the observations of SALTER and BEST (Brit. med.J. 2: 354 [1953] ) take on added significance. It is possible that some of the patients studied here show the growth promoting effects of insulin.
L.B. HOLMES (U.S. Public Health Service Hospital, Staten Island): As you mentioned, Drs. FRANTZ, SOELDNER, CRAWFORD and I presented at these meetings last year data from nine children who have exhibited normal growth in spite of hypopituitarism following the removal of either a craniopharyngioma (8) or a third ventricle cyst (1). Those children with the greatest decline in growth rate before surgery had the greatest growth spurt postoperatively. After this 'catch-up' growth spurt their rate of growth was normal. None of our patients had measurable levels of plasma growth hormone after insulin hypoglycemia, fasting or vigorous exercise.
Most of our patients exhibited extreme hyperphagia after surgery. One boy weighed 250 pounds at age 15 years. Some were able to lose much of their excess weight after their appetite was normal. Our insulin measurements are from 6 children, two obese and four only slightly obese. The insulin levels correlated with the degree of obesity in that those near normal in weight had low normal levels similar to children with hypopituitarism alone and the obese patients had high normal insulin levels as is found in normal, but obese individuals. Our data, therefore, argues against the suggestion that serum insulin was responsible for the normal growth in these children with hypopituitarism. Patients who lost the most in height preoperatively gained the most postoperatively; those who lost less in growth rate preoperatively were also presumably catching up to a predetermined level. This suggests that a growth regulating mechanism, unrelated to growth hormone responsiveness to insulin or arginine stimulation, is operative despite hypopituitarism and stalk section.
E. H. SOBEL (Albert Einstein College of Medicine, New York): You mentioned that the boy had no signs of sexual development. Did the girls have any mammary gland stimulation or any signs of estrogen effect?
F.M.KENNY: Estrogen effect was absent on urocytogram (Pediatrics 38: 436 [1966] ) in both girls.
The older girl was markedly obese, and although 'breast tissue' was abundant, it was impossible to determine whether part of this constituted prolactin induced hypertrophy. Her prolactin level was elevated.
The younger girl was not obese and did have palpable breast tissue suggesting the possibility of elevated prolactin, although it has not yet been measured. Although insulin has been demonstrated by immunoassay in fetal pancreas as early as 13 weeks of gestation, the controls of insulin secretion in the human fetus and the role of transplacental transfer as a source of insulin are unknown. In 17 pregnant women scheduled for legal therapeutic abortions by abdominal hysterotomy at 14 to 16 weeks of gestation, fetal plasma insulin response to glucose infusion and insulin transfer across the placenta were studied as follows: (1) glucose was infused via umbilical vein to 7 fetuses in situ; (2) human insulin I 131 was infused similarly to 3 fetuses in situ, and (3) insulin I 131 was infused continuously for 4 to 6 hours to seven pregnant women via a peripheral vein. Insulin was measured radioimmunologically and, following the infusion studies, was precipitated quantitatively by double antibody methods. During fasting, no difference was observed between fetal and maternal plasma glucose or insulin levels (ins. cone. ±SD = 5.9^2.3 and 5.1 ±3.2 ,«U/ml respectively). Although glucose administered to the fetus raised the fetal plasma glucose 1 to 844 mg/100 ml without changing the maternal level, both fetal and maternal plasma insulin levels were unchanged at 5 and 10 minutes. Human insulin I 131 was not transferred across the placenta in either direction. Early in human gestation, the fetal pancreas appears to be the major source of fetal insulin, and the fetal insulin secretion rate may be relatively unresponsive to acute changes in blood glucose concentration. Discussion F. C. BATTAGLIA (University of Colorado Medical Center): Why did you choose to sample the umbilical vein after the injection of glucose to see if the pancreas was putting out insulin, rather than the umbilical artery?
I noticed that in studying the injection of labelled insulin into the fetus, you changed the experimental format and sampled the umbilical artery rather than the umbilical vein. P.A.J. ADAM : We sampled both, and there were no differences between the umbilical artery and the umbilical vein in the fetuses. However, we were not able to sample the umbilical artery in every fetus, due to the problems which occur with a small vessels that early in gestation, so we recorded the umbilical vein samples.
R. E. GREENBERG (Stanford University School of Medicine, Palo Alto): In your last slide there was a tremendous difference in the presumed rate of disappearance of insulin from fetal blood. The first patient had about 5 percent of the counts at eleven minutes that were present at six minutes; whereas the other two were almost identical.
One would certainly expect a much more rapid rate of removal of counts than was seen in the last two patients. Do you have any explanation for this? P.A.J.ADAM: We have no explanation for this discrepancy in the results. There are problems when one is injecting and sampling from a similar site. We do not know specifically what happened to the circulation in every fetus, and we presumed that the differences had something to do with this.
A.K. BROWN (Medical College of Georgia): You mentioned having done some studies with amniotic fluid. Did you have any opportunity to increase the glucose concentration in the amniotic fluid and study the response to administration of glucose by that route, since the infant would swallow the glucose in that fluid ? P.A. J. ADAM : We did not use the opportunity. N. M. NELSON (Boston Lying-in Hospital): There is a suggestion from work in lower forms than human that fetal insulin response is mediated by the stimulus of amino acids, rather than glucose. I wondered if you had had an opportunity to test that in this preparation. (pH < 7.20 ) and yet were vigorous at birth. An explanation for this disparity was sought by examining maternal-fetal acid-base relations during labor in 50 cases. Where the mother was not acidotic (mean pH 7.42) the infant was in good condition at birth, maternal-fetal gradient for pH and base deficit being 0.17 units and 2.6 mEq/1 respectively. Mothers who became acidotic during labor (mean pH 7.36) were found to have acidotic fetuses (mean pH 7.15) who were nevertheless vigorous at birth, the gradient for pH and base deficit in this group being 0.21 units and 4.8 mEq/1. By comparison, the maternal-fetal gradients when the infant was both acidotic and depressed at birth were 0.27 pH units and 7.0 mEq/1. These observations emphasize that maternal acidosis is reflected in the fetus and that true assessment of the significance of fetal acidosis must take maternal acid-base state into account. E.T. BOWE: In the initial part of our studies the samples were obtained by the authors of this paper. Currently all our samples are being done by our resident staff.
As far as complications are concerned, there were three complications in this series of 355 babies; one case of infection, and two of bleeding.
In our total series now, which numbers 670 babies, we have had a complication rate of less than 1 percent, in that we have had six complications up to the present time.
F. C. BATTAGLIA (University of Colorado Medical Center): Do I understand one of your earlier slides correctly? It seemed to me you had a group with low Apgar scores in which 13 percent showed acidosis by scalp sampling and 12 percent showed meconium staining and a decreased fetal heart rate. Is that correct? E.T. BOWE : Yes. In that group there were 12 percent who showed both of the classical signs of fetal distress, and 13 percent of them were severely acidotic.
F. C. BATTAGLIA : So there was a 1 percent difference between acidosis and using the classical signs of fetal distress? That hardly seems a significant difference. In both instances, over 80 percent of the infants that were depressed had not shown a severe acidosis by scalp sampling. I think that is important since the clinical significance of what you term 'moderate acidosis' has not been verified. E.T.BOWE: NO. That figure of 13 percent was what we termed severe acidosis-pH less than 7.10. Fortyfive percent of those babies had a pH of less than 7.20.
T. K. OLIVER (University of Washington School of Medicine): If the mother is acidotic, do you recommend that she be treated? Dou you have experimental data to suggest that correction might in fact be possible since in experimental animals bicarbonate transfer across the placenta occurs very slowly? Finally, what effect did correction of maternal acidosis have on fetal oxygenation? E.T.BOWE: We have two clinical cases where we have treated maternal acidosis, observed in the first stage of labor. We have samples obtained from the fetus and the mother serially after she has received bicarbonate therapy, and the fetal pH returned toward normal, as the mother's did. There was a lag in time, but both did return toward normal.
G.EMMANOUILIDES (UCLA-Harbor, Torrance, Cal.): Have you correlated birth weights and acidosis in these 'full-term infants' ? In other words, have you observed differences between the small-for-date or malnourished infant and the normal full-term infant? It is possible that 'dysmature' babies may have higher incidence of acidosis during 'normal' labor.
E.T. BOWE : We do not have any statistics relating to birth weight. We do have some cases where we have noticed sudden severe acidosis in the so-called dysmature baby.
CD.COOK (Yale University School of Medicine, New Haven): Were any of the oxygen tensions in the fetuses measured? The vigorous acidotic babies might well be explained by the beneficial effect of acidosis in the mother on the transfer of oxygen to the fetus. E.T. BOWE : We did do pO 2 's on some of these babies; but we do not have them in the babies that were acidotic as a result of maternal acidosis. We did find that the pO 2 did not correlate very well with the clinical condition. . Ninety-one infants with respiratory failure secondary to primary pulmonary disease and a birth weight over 1,000 g have been managed in a negative pressure respirator (Air-Shields) over a 3-year period. Of these, 87 were due to RDS and 4 resulted from massive meconium aspiration. Respiratory failure was indicated initially by arterial blood gas tensions (while breathing 100 % O 2 ) of pO 2 < 40 mm Hg, pH < 7.10 and pCO 2 > 75 mm Hg in the initial 47 cases; subsequently raised to pO 2 < 50 mm Hg, pH < 7.20 and pCO 2 > 70 mm Hg for the remainder. Fifty-four (59.3 %) of the infants survived the respirator usage and 47 of these (51.6 %) were subsequently discharged home alive and well. Times in hours to normalization of blood gas values on the respirator were as follows (mean ±SE): For pO 2 , 10.5±2.7; for pH, 11.6±1.6; for pCO 2 , 22.6±4.5.
These values indicate that the respirator is more efficient in promoting oxygenation (raising pO 2 ) than ventilation (lowering pCO 2 ). They also suggest that the observed acidosis is in large part secondary to the hypoxia rather than the result of CO 2 retention. Time of total respirator dependency (mean ±SE), prior to commencement of weaning, for the survivors was 53.7 ilO.5 hours. All the infants were managed without the use of endotracheal tubes although the respirator usage and/or 100% oxygen were administered either continously or intermittently for periods of up to two weeks. There have been no instances of so-called 'respirator lung disease' in either the survivors or the deaths, suggesting that the use of high oxygen concentration by itself is not a major factor in the pathogenesis of this complication.
Discussion
M. STAHLMAN (Vanderbilt University School of Medicine, Nashville): We have been using negative pressure ventilators since 1961, and have had very similar experience to his. During this period, particularly in the early phase, we used the criteria for putting babies in the respirator, since we did not know its effects of complete collapse, prolonged apnea, and, finally, we used persistent pO 2 of less than 30 mm of mercury in a 100 percent oxygen environment.
Knowing Dr. STERN'S elevation of this pO 2 criterion first to 40 and then to 50, we went back and looked at our own material to see how many babies survived without a respirator, and of 200 babies, only four got by without being respired, with persistent pO 3 's of less than 40, and only eleven with persistent pO 2 's of less than 50.
This makes a very small number of babies who will survive without ventilation, once they reach this stage, and I would agree that our criteria now can be elevated to much more relaxed numbers. We are not nearly as afraid of using a ventilator, particularly a negative pressure ventilator, as we once were.
I would like to reinforce that in babies on whom negative pressure alone has been used, we have not seen this syndrome of pulmonary dysplasia either on the acute pathology nor in the follow-up x-rays of any of the survivors.
L. STERN : I would add to this that the pO 2 value of 50 has now been arrived at by several people working with other types of respirators on the basis of their own experience, the group in South Africa with Dr. HEESE and the group with Dr. SWYER in Toronto.
I think the other questions that one perhaps should address oneself to now are these. Knowing that one can get away with this reasonably safely under certain circumstances, should one permit a baby to remain at a pO 2 lower than normal? Do we know what a reasonable pO 2 is for its safe future development?
I do not know the answers to these questions, but it is certainly worthwhile finding out.
R. L. DAY (Mount Sinai School of Medicine, New York): Was the arterial blood sampled from above or below the ductus? L. STERN : The blood is sampled from the umbilical artery and I think that in most instances this is below the ductus.
This poses a problem as to what kind of values you are getting. We had in the early phases of these studies some comparative values between right radial artery and umbilical artery below the ductus. Until you get into disastrous trouble, and the situation becomes terminal, we found very little difference between the two, of the order of 1 or 2 mm Hg. I think that when the situation deteriorates to the point of 20 mm Hg or 10 mm Hg from the umbilical catheter, these very low values may in part be a reflection of true right to left shunting. Either way, they indicate a severity of disease from which spontaneous recovery is unlikely.
R.E. HELPER (University of Colorado School of Medicine): Do you have objective criteria which permit you to determine when to discontinue the respirator, anticipating that the child will then have a fatal outcome? L. STERN : No. I think that there are two rules to this business. One is that you must take on all comers, irrespective of what they look like. We have had one experience with a baby who was pronounced dead and wrapped in a sheet, and who is now walking around at 15 months of age and looks fine.
Moreover, sometimes the situation can look irretrievable for a long period of time, yet once in a while, despite all your worst expectations, it turns out the other way around. One can make some prognostic predictions from the data relating to time already survived in the respirator, but on an individual basis the answer is no.
CD.COOK (Yale University School of Medicine, New Haven): Did you make any attempt to treat the acidosis with THAM or bicarbonate? L.STERN: Yes. I should have mentioned that we resort to respirators only after complete correction or attempted correction with bicarbonate and fluids. We have not used THAM for this purpose, but the respirator has been used by us only after attempted correction and the use of maximal oxygen concentration (100 %) in the inspired air.
The one other thing that we try and make sure of is temperature. Ours is a referral nursery, and many of these infants come in from the outside cold. If you go on the gases in this state you may be misleading yourself. Often if the baby is left to be heated and warmed the situation improves remarkably. If he is not breathing it is a different matter; but we try and avoid using an initial admission arrangement until we think we have gotten the situation as stabilized as we can.
R. M. SMITH (Children's Hospital, Boston): In our experience with this respirator we have had several difficulties, first, with rubbing off of skin at the neck; secondly, the gastric distension that may occur; and thirdly, the development of very marked inguinal hernia tion from the suction of the machine. Have you had experience with these problems ? L. STERN : These are problems which I think everybody gets to cope with by a series of trials and errors.
We do not use the cuff around the neck, we try and use it low down, almost over the collar bones, because we ran into this neck problem at the beginning, too.
The question of gastric distension; we have seen this. We simply put a tube down in the stomach and suck out the air.
The inguinal hernia I have not seen, but I would assume that this is just an extension of the pressure effect.
N. M. NELSON (Boston Lying-in Hospital): Can you give us an idea of what your mortality experience was with a comparable group of infants previous to respirator therapy? I ask this because Drs. SILVERMAN and SINCLAIR, in an on-going comparison of respired versus non-artificially respired babies, were not able to show significant improvement of survival attributable to the respirator.
L. STERN: The study you refer to applies to a different group of infants who were managed from shortly after birth in respirators because of the establishment of the diagnosis of respiratory distress syndrome. We have gone into respirators only with criteria of severe and in our experience almost invariably fatal respiratory failure; criteria far more severe than those of Drs.
SILVERMAN and SINCLAIR. Since we arrived at our initial criteria for respirator usage by having seen a large number of cases with the inevitable loss of children with such blood gas values, the mortality experience could fairly be placed as 100 %. One can probably designate this as a 'control' group; we would rather refer to this as our own previous failure.
I think however, there is a major difficulty with this kind of historical sequence. This is the question of time. There is no question that the mortality rate for all infants in our nursery is better. It gets better every year; but I think that this may be at least in part a function of time and with it experience as well as any therapeutic changes.
We have felt also that because we have no control over the babies we get referred from the various nurseries, a much fairer comparison is to apply these criteria to some of our suppliers. In other words, what kind of an impact have we had on the nurseries which send their infants to us, provided they send them all to us? We have chosen for analysis three of these and we think that we have been able to show a reduction in their mortality from hyaline membrane disease, because they depend on us as a center. It is very easy to show a reduction in mortality from hyaline membrane disease in our nursery, but I think it would be misleading to say that it was the respirator alone that is responsible for this. It is therefore better and perhaps more meaningful to assess the improvement for the community nursery suppliers.
J. STRAUSS (Children's Hospital, Los Angeles): Drs. SILVERMAN and SINCLAIR have repeatedly emphasized the importance of simultaneous controls for the evaluation of therapy of the respiratory distress syndrome. Dr. SINCLAIR has summarized in his paper in Pediat. Clin. N. Amer. 1966, all the proposed treatments for this syndrome; it is clear that evaluation without controls can be misleading.
We have attempted to establish controls in trying to evaluate alkalinizing agents, without control or assistance of respiration. I wonder whether it is possible, Dr. STERN, to devise a workable controlled study with your patients.
I realize it is a very difficult proposition, but probably until we can compare results of treated sick babies and controls (selected in one fashion or another) the conclusions are always going to be subjective, and there is going to be discrepancy of interpretation.
L. STERN : I think what is important is not a matter of interpretation. I think also if you talk about controls, you have to be very specific about what your end point of the control is. Here it would be very easy to do a control, because there is enough experience now from Dr. STAHLMAN, and ourselves, and others that if you do a yes-or-no trial on a respirator at the blood gas levels we are talking about, you are a winner each time because most of the 'controls' will die. I do not think this is what is needed, nor is it any longer justifiable.
I think that if you are going to do a control, you must pick some other end point than survival, because the baby's survival is a multifactorial arrangement. One cannot blame a respirator for the death of an infant because of the nursing care that particular night, or if it was a new resident that particular night who was not as good as the one next or previous night. We must use a much more specific definitive end point, e.g., a quantifiable blood gas, with the ability to improve it as a measure of respirator success. Adult physiologists would never evaluate a respirator on the basis of mortality. Yet we continue to do so, thereby permitting ourselves the luxury of having a respirator to blame for our lack of therapeutic success.
I think this can be done, and that several groups are doing it using variations of this, where the end points are neither death nor survival, but rather better or worse respiratory status.
Moreover, the results of any single respirator group's experience do not respresent a necessarily repeatable standard for others. The factors that go into it do not only depend on the machinery. They depend on an entire network and complex of people and services which may not be available, for better or for worse, to every community and in every unit.
M. DELIVORIA (Graduate School of Medicine, University of Pennsylvania): In those babies who your negative pressure respirator did not improve, did you try to use the positive pressure respirator as an alternative? L. STERN : Sometimes. One of the reasons we have not done so more often is that our previous experience with positive pressure respirators has been very bad. But again this is a function of time. This was way back when. I left out a part of the story in between getting the criteria and starting with the negative units; we tried the positive for a year and a half, and our overall results were very bad.
Moreover, we felt committed to keep on with this because of the fact that in some instances we certainly were not able to be certain that things were not going to improve. So in the overall the answer is no, and although we have tried it on several occasions, it has not been particularly helpful to us.
J. BRADY (San Francisco General Hospital): I notice you do not seem too concerned about arterial pO 3 's between 200 and 300, and I wonder, although you have not seen pulmonary dysplasia, whether you have seen any retrolental fibroplasia in your surviving babies.
L. STERN : I would like to correct that. We are very concerned about the pO 2 . I showed that slide because it is a good example of how easy it is to raise the pO 2 ; but, we would not permit it to remain at that level.
We try to aim for a pO 2 , between 80 and 100 mm Hg. We are not always successful. Of the forty-seven survivors we have one baby with retrolental fibroplasia. This is a baby for whose disease we have to accept full responsibility. We knew exactly what was happening with this baby. His pO 2 went rocketing to 400 in the respirator and fell to 30 without it. We were at the time not sophisticated enough to devise a method of carrying him in the respirator in anything short of 100 percent oxygen. We have since that time learned by necessity to manipulate this so that the inspired concentrations can now be varied. This is the only baby so afflicted. All our babies are routinely examined ophthalmologically before they go home from the nursery, and again three months later. Yale Univ. Sch. of Med., New Haven, Conn, (introduced by CD. Cook). In pediatric research, informed consent of parents is of critical importance from both the ethical and psychological points of view. In this study we present pertinent findings based on preadmission interviews with parents of 140 children who were admitted electively to a pediatric clinical research unit. In these interviews, the understanding and attitudes of the parents about the care and investigation of their children were major foci. These parents viewed 'Research' hospitalization as an impersonal means to increase scientific knowledge by the study of a disease process and/or its treatment. 'Clinical' hospitalization was viewed as diagnostic and/or therapeutic. Despite prior discussion and consent for hospitalization, 61 parents expected a 'Clinical' hospitalization. Sixty parents expected the hospitalization to be both 'Clinical' and 'Research'. Only 15 parents viewed the hospitalization as primarily research; 4 were unclassified. Although research was an anxiety laden concept, consent was rarely withheld. The prospect of therapeutic benefit, reassurance of minimal physical risk, the presence of fear and guilt, and a lack of a sense of choice were the most prevalent reasons expressed for giving consent. It was concluded that the followsing 3 questions should be systematically studied to enhance a parent's choice in giving consent: (1) In what respects do the proposed studies constitute research as distinct from diagnosis and treatment? (2) What are the psychological and physical risks attached to the studies? (3) In what alternative ways might the child's medical needs be met? Discussion A.B.BERGMAN (Children's Hospital, Seattle): I suspect many of us physicians would become quite anxious when shown that our ministrations do not always result in patient benefit. What happened when you presented these findings in your own department? Were any procedures modified, and were you able to assess any change afterward?
A.T. MCCOLLUM : The physicians who admit patients to the research center all demonstrate concern for the psychological as well as physical well-being of their patients and families. In the individual instance, when parental fears or misconceptions were reported back to the responsible physician, there was invariably an attempt at further clarification and allaying of fears.
With respect to program modification, some of the findings from the earliest phase of this study contributed to the development of the policy requesting review of the research protocol between physician and parent and obtaining written parental consent prior to admission.
We are presently designing an extension of this study in which we shall systematically examine and compare the expectations and concepts of research of parents and physician-investigators. We hope this will elucidate the question of how and when parental misconceptions and distortions occur. In addition, we are interested in examining the matter of effective doctorparent communication, and in trying to identify factors which contribute to effective communication.
I can best answer your question by saying that we are at this point trying to design well-thought-through studies which will result in more definitive information.
J.B.RICHMOND (Upstate Medical Center, Syracuse, N.Y.): I would gather from the presentation that you treated your population of children entering the center as a rather homogeneous group. I wonder if you have any comments to make on the reactions of the parents -their attitudinal sets-in relation to the unique problems (or illnesses) which the children presented. Did you see any clustering of attitudes in relation to specific illnesses?
Did you use the same type of interview or interviews over time? In other words, it may very well be that, as parents make an accommodation to the staff and to the routine of the center, there might be quite an attitudinal shift. I assume that your presentation is based entirely on the preadmission interview, but I wonder if you have any data relating to shifts over time.
The other question that I would raise is brought out only in relation to your comments about decompensation on the part of one parent or set of parents. Do you feel that this kind of inquiry at a time of crisis-such as entry into the center-might have any potentialities for disrupting what might be fairly functional defenses which the parents may be utilizing?
A.T. MCCOLLUM : Our data were examined with the question you pose first in mind. There was no significant clustering of attitudes related to the child's disorder (whether genetically transmitted, inborn or acquired) or the prognosis. Neither was there clustering related to the gross characteristics of the parent-child relationship, nor to the identity of the physician-investigator.
We have as yet done no systematic examination of parental attitudes during or following hospitalization. Many parents were interviewed further during hospitalization by me, and there were numerous informal transmissions to the physicians and nursing staff. It is our impression (without systematic data to substantiate this) that there is usually an attitudinal shift in the direction of increased trust as parents directly observe the concern of the staff for the total well-being of their children.
With respect to your third question, we would agree that this potentiality exists in all interviewing in sensitive areas. In the multi-purpose interviews we have described, there was of course a continuous apparaisal of the nature and effectiveness of the defenses being utilized by parents. It was never attempted to elicit information at the risk of stimulating overwhelming anxiety, or to attempt to penetrate the defensive system being observed. An impressive number of parents expressed the view that the interviews had been beneficial to them in offering an opportunity for examination of fears, for clarification of questions, and for active planning to safeguard the well-being of the children.
B. M. KORSCH (Children's Hospital, Los Angeles): We have been engaged in a large-scale study of doctorpatient communication involving acute, episodic illness in an out-patient department. We have one additional set of data, the recordings of the interaction between the doctor and the patient. Thus we were able to compare the responses of the patients and the patients' perception of the diagnosis to what the doctor had indeed said. These observations highlight something which I think you implied in your discussion; namely, that saying something to a patient should in no way be taken to mean that the patient has heard this, or understood it. I think we have a sort of deplorable tendency to feel that we have done our duty when we have said something, and do not feel that it is our responsibility to investigate to what extent and how this has been understood.
For this reason, I liked the emphasis in the conclusion on the questions that ought to be investigated, rather than giving us admonitions as to what we should say. I think you have raised the principle that we ought to investigate with the parents these four areas, and I think that is a very healthy emphasis. (introduced by Edward C. Curnen). Tyrosinosis was treated from 5-11 months of age with tyrosine (Tyr) and phenylalanine (Phe) restriction and from 11-15 months of age with methionine (Met) restriction as well. On the first regimen, there was striking improvement in renal, hepatic, hematological and osseous manifestations. On the second regimen, hepatosplenomegaly persists but the child is otherwise normal. Acute loads of L-Phe and L-Tyr, while on the first regimen, revealed no intolerance. There was delayed metabolism of an acute load of LMet. Unrestricted Tyr and Phe for one week resulting in tyrosinemia and tyrosyluria again.
Enzyme assay of liver, after 3 months on the first regimen, demonstrated a decrease in Met-activating enzyme and cystathionine synthatase, but normal amounts of cystathionase. This may explain the methioninemia without homocystinemia observed in this syndrome. Para-hydroxyphenylpyruvic acid oxidase (pHPPAO), Phe hydroxylase and Tyr transaminase were all strikingly reduced (collaboration with Drs. LADU and ZANNONI). These results do not support previous reports that the etiology of this syndrome is an specific deficiency of pHPPAO and that the methioninemia is secondary to generalized hepatic failure. The response to a diet low in Phe and Tyr suggests that the reduced ability to metabolize Tyr may play a pathogenetic role. G. CARPENTER (St. Christopher Hospital, Philadelphia) : During the past six years, we have measured six-hour fasting serum amino acids by ion exchange column chromatography in thirty-one jaundiced infants ranging in age from four weeks to three and onehalf months prior to operative cholangiogram and liver biopsy. Their diets had not contained additional protein and had been similar in total intake, content and vitamins. Hematologic, infectious and metabolic causes of prolonged jaundice other than biliary atresia and/or neonatal (Giant cell) hepatitis were preoperatively ruled out.
Fourteen patients were surgically diagnosed as having biliary atresia; their serum methionine (Met) ranged up to 0.6 mg % and serum tyrosine (Tyr) up to 2.4 mg %. Of the remaining seventeen patients with diagnoses of neonatal hepatitis, eleven had met values above 0.6 mg% with the highest remarkably at 12.1 mg %. The Tyr was also elevated above 2.4 mg % to 6.2 mg %. Other fasting serum amino acids were not elevated. Serial studies on this group of infants with elevations of Met and Tyr revealed a return to normal values coincident with post-opperative clinical and chemical recovery.
We have proposed this temporary methionine and tyrosine amino acid elevation in the hepatitis group as a potential aid in the differential diagnosis of prolonged G. E. GAULL : It would be of interest to study the trans-sulfuration enzymes in such cases, but we have not yet done a systematic survey of various types of neonatal hepatitis.
R. C. HARRIS (Babies Hospital, New York): May I interrupt, and say that we have surveyed the giant cell hepatitis patients with screening tests, and have not gotten any evidence of increased methionine or tyrosine in the group of patients we have seen, in which these patients might be included.
However, these patients are much different from those with neonatal hepatitis, in that the bilirubinemia was not as dramatic, and the signs of obstructive jaundice were not as dramatic. So I think this is an entirely different group of patients.
G.E.GAULL: What I was about to say to Dr. CAR-PENTER is that I have not examined either the plasma amino acids or the enzymes in any of these entities in a systematic and quantitative way. I think that this would be a very interesting problem. R.A.CAMPBELL (University of Oregon Medical School): There is a problem in the nomenclature in the tyrosine disorders. First, is it appropriate to call this pediatric disease tyrosinosis, when the only other case of tyrosinosis described was that of a 49-year-old Jewish gentleman who had a history of myasthemia gravis?
Secondly, Drs. BUIST, JACINTO and I have had the opportunity to study an infant with true tyrosine transaminase deficiency. He lacks the clinical stigmata of the infants and children whose disease has been variously called tyrosinosis and tyrosinemia. That is, hyperpigmentation, hepatomegally and rickets are absent. Serum and urinary amino acids are normal with the exception of tyrosine which is grossly elevated.
A very interesting finding discovered by Dr. FELL-MAN and his associates at our institution was the presence of two liver tyrosine transaminase enzymes, one in the cell sap (soluble) and the other on the mitochondria. Our patient was lacking in the cell sap enzyme.
How would the knowledge of two apparently separate and distinct tyrosine transaminase enzymes alter the interpretation of your results?
Finally, with the confusion in the literature concerning nomenclature, how about calling your disease tyrosine disorder type V?
G.E.GAULL: I think you can call it anything you please. My message was that, whatever you choose to call this entity, it is not a specific deficiency of parahydroxyphenyipyruvic acid oxidase, in the sense that homocystinuria is a specific deficiency of cystathionine synthase.
Of course, I am aware of the controversy amongst those who think it is a specific deficiency of para-hydroxyphenylpyruvic acid oxidase, about whether to call it tyrosinemia or tyrosinosis. I, for one, have called it something so we could get it on the program. I think acute tyrosinosis with hypermethiominemia is probably as good as any until we find out what the etiology of this group of patients really is.
With regard to your soluble tyrosine transaminase deficiency, I heard that very interesting paper at the Federation Meetings last week, and I would say the following:
Dr. LADU did not separate the particule-bound from the soluble tyrosine transaminase, as you did, so that it is not clear which tyrosine transaminase was reduced. However, what you described does not seem to be the same clinical entity.
I was a little mystified on a single hearing of this paper about the interpretation of your results. I thought that the interpretation that was given there was interesting, but it seems to me that more work must be done before it can be accepted as entirely explaining the biochemical findings. For segregation analysis, classical PKU families were subclassified into 20 typical (mental retardation in affected sib) and 5 atypical (normal I.Q. without treatment in affected sib). Typical PKU, atypical PKU, and hyperphenylalanemia appear to segregate independently and in each case the mode of inheritance was consistent with autosomal recessive. PA tolerance tests showed considerable variation but mean values did not differ significantly in the three groups.
The average I.Q. was 84 in treated typical PKU index cases, 61 in untreated typical PKU index cases, and 49 in untreated sibs of typical PKU index cases showing beneficial dietary effect. In contrast, the value was 104 for treated atypical PKU index cases and 95 for untreated atypical PKU sibs indicating that treatment had no negative effect. Finally, the average for treated and untreated hyperphenylalanemia index cases were 93 and 100, suggesting no treatment effect.
These data suggest that elevated PA detected by newborn screening is not synonymous with mental retardation ; however, at the present time, it is not possible to predetermine which infants have typical PKU and require treatment.
A. SASS-KORTSAK (Hospital for Sick Children, Toronto) : What made the authors pick the magic number of 20 mg %; and after they had picked this number and established two groups, why did they call one group hyperphenylalaninemia and the other group phenylketonuria and then show at the same time that they can really not distinguish between these groups on any other grounds but the phenylalanine levels ?
I have a strong suspicion that you have a lot of true phenylketonurics in Group 1, although you may have in one and even in both groups transient hyperphenylalaninemia.
The duration and the genetic background of the defect, the actual enzyme defect, needs to be defined. J. L. BERMAN : The number of 20 mg % certainly is magic in a way. One has to select a number on which to base a hypothesis. We chose this because the national collaborative program for phenylketonuria had decided that this is the level at which a patient may be admitted to the study. However, we recognize that many of these cases may have to be reinterpreted and placed in another category. Furthermore, when you take the data and use 15 mg% or 25 mg% as a cut-off point, essentially very little change occurs in the mean I.Q. levels or in the numbers of patients in each category.
G.E.GAULL: HOW are you able to sort out the environmental stimulus of this 'multidisciplinary' approach from the effect of the diet on ultimate I.Q,.?
J. L. BERMAN : I am not quite certain that I understand the question. However, I will say that in six of the seven states that we studied complete ascertainment was attempted. Thus, virtually all cases born in the study years were included in the data.
G.E.GAULL: What I have reference to is this: You now feel that you have eliminated the fallacy of selecting the cases in different ways, which is one of the criticisms that has been levied against previously reported favorable results with the low phenylalanine diet.
You now take a population of patients with phenylketonuria who have all been ascertained by screening procedures, treat them by phenylalanine restriction and compare them to their untreated siblings and find they have a higher average I.Q,. This is still an 'apples to oranges' comparison in the sense that this group, by the very nature of the 'multidisciplinary team approach', has grown up in quite a different environment. The untreated sibling is not at all a valid comparison.
J. L. BERMAN : There is no way for me to tell whether the enthusiasm of treating a patient in less than 30 days would have an effect.
J.HODGMAN (University of Southern California, Los Angeles): Most of your later cases were found by newborn screening. Could you give us the details of the screening, the age of the infants, whether the babies had been on milk diets, whether repeat tests were done in the newborn period? J. L. BERMAN : I can not give you the complete breakdown of this. Almost all the cases discovered in newborn screening were within the first 30 days of life. Some were on the breast, some were on whole milk, some were on Similac, etc. However, we have made careful analysis of what the newborn screening blood levels were, and in almost all instances the child has had more than one level above 20 mg %.
S. KARELITZ (The Long Island Jewish Hospital, New Hyde Park, N.Y.): Since the chances are that with each pregnancy two out of four offspring will be carriers, and that some of these may be hyperphenylalaninemias, and others may not, do those who do not manifest hyperphenylalaninemia show any change in development.
J.L.BERMAN: Not that I know of. Pediatrics and Biochemistry, and. the Joseph P. Kennedy, Jr. Mental Retardation Research Center, Chicago, 111. The Marfan syndrome is an autosomal dominant disease of unknown etiology. Skin fibroblast cultures from two siblings showing typical features of the disease demonstrate the marked intracellular accumulation of metachromatic granules. The granules are distributed through the cytoplasm somewhat differently from those in Hurler fibroblasts. Isolation yielded 6-8 times as much intracellular acid mucopolysaccharides as obtained from normal skin fibroblasts. The quantity was comparable to that found in Hurler cells. Electrophoretic separation indicated the presence of a spot with the mobility of hyaluronic acid and one with the mobility of a chondroitinsulfate.The ratio of hyaluronic acid to chondroitin sulfate was approximately 2:1, in contrast to the ratio of 1:4 previously observed for Hurler's syndrome. These findings suggest that the Marfan syndrome is due to a defect in the metabolism of acid mucopolysaccharides which differs from that of the Hurler syndrome. (Supported by USPHS grants AM-05996, FR 00305 and Chicago Heart Association.) Discussion E. KOHLER (Marquette University, Milwaukee): It has also been reported that hydroxyproline is increased in fibroblastic cultures by some Czechoslovakian investigators (MACEK et al., Humangenetik [1966] ), I wondered if you had found any increased hydroxyproline. Also have these patients' urines been checked for amino acids, such as homocystine? E. KOHLER : We have also cultured fibroblasts from a newborn with Marfan's, and have not been able to see this kind of metachromasia with staining.
R. MATALON : The failure to demonstrate metachromasia can be the result of many factors. The cell age in culture and their culture conditions are important. The staining techniques are of great importance since the polysaccharides might leak from the cells under different staining conditions. In our hands, the method of HAUST and LANDING (J. Histochem. Cytochem. 9: 79 [1961] ) with some modification, depending on the cell density, has been the most successful in demonstrating metachromasia.
S.I.GOODMAN (University of Colorado Medical Center): Patients treated with penicillamine and lathyritic animals have been reported to develop collagen abnormalities. Have you examined fibroblasts in these conditions? R. MATALON : We have not studied patients treated with penicillamine. Studies on chick fibroblasts grown witn lathyritic agents by Dr. CHARLES LEVENE a few years ago in our laboratory did not exhibit the characteristics described in the Marfan fibroblasts.
H. G. DUNN (University of British Columbia, Vancouver) : Have you tried to apply this technique to untreated homocystinurics? And do you think that your technique might be applicable to the prenatal diagnosis of Marfan's syndrome? R. MATALON : I have no data with respect to homocystinuria. We have cells in culture from homocystinuria, grown by Dr. FRANK THORP, which are currently under study.
H. MEDOVY (Children's Hospital, Winnipeg): I think Dr. DUNN was referring to the possibility of examination of amniotic cells prenatally. R.MATALON: We have not conducted studies on cells cultured from amniotic fluid, but we know that this is being done. We would like to caution that though this method may prove to be useful in chromosomal aberrations, or autosomal dominant diseases such as the Marfan syndrome, a diagnosis should not be made on staining quality of the cells alone. In Hurler's disease this technique might also be misleading since the heterozygote cells in culture show metachromasia similar to the homozygote cells. A hasty diagnosis of Hurler's disease in utero might lead to disastrous results. Extensive investigation is needed before the interruption of a pregnancy is attempted. D.W. SMITH (University of Washington School of Medicine): Have you had an opportunity to look at any tissues of patients with Marfan's, other than the fibroblasts, to see whether there is storage of hyaluronic acid in any other tissues? R.MATALON: NO, unfortunately not. I mentioned here that one of the first changes in the artery is spaces filled with metachromatic granules. This is what I have read and seen published, but there is no analysis of this material. We will probably go after that, to see what it
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Cancer Deaths in Sibs. ROBERT W. MILLER, National Cancer Institute, Bethesda, Md. Doubt has been cast on the concordance rate of 20 % for childhood leukemia among identical twins in the United States because of inability to confirm this observation in a study of equal size in England and Wales. Among sibs other than twins there are reports of an increased risk of leukemia (3 times normal), conflicting results with respect to brain tumors, and little information as to other neoplasms. To clarify the extent to which childhood cancer causes death of sibs, data were abstracted from the death certificates of all (21,659) children who died of cancer in the U.S., 1960-64. The list was alphabetized by child's last name, and sibs were identified primarily by matching the mothers' maiden names. The results revealed 5 pairs of like-sex twins with leukemia, all under 6 years of age (none was previously reported in the literature). This number was close to the 9 pairs expected if the concordance rate for identical twins were 20 %. The occurrence of leukemia in 5 pairs of sibs other than twins did not exceed normal expectation. There were 6 pairs of sibs with brain tumor, well above the expected value of 0.4. The occurrence of brain tumor in one sib and bone or muscle cancer in another (6 families) was also excessive. In 4 other sib-pairs no neoplasm was overrepresented. These findings can be of value in defining etiology, in detecting neoplasia early among sibs at high risk, and in counseling families of children with cancer.
Discussion
W.W. ZUELZER (Children's Hospital of Michigan):
This approach of Dr. MILLER'S is tremendously valuable, and I hope that he and his team will persist in gathering data of this kind. In describing the twin pairs, you used the term 'presumably genetically induced disease'. You have been, I believe, impressed in your own work with the role of chromosomal abnormalities in the genesis of leukemia; but would you agree that this may still be only a predisposing factor, and, if this is so, that the genetics in these kinds of situations may be a rather different one from classical genetics, in the sense that it only increases the risk if a family or individual carries such a chromosomal abnormality? R.W. MILLER: Yes, I certainly would agree because apparently only 20 percent of identical twins are concordant for leukemia. Eight percent of co-twins escape. This suggests that there is some environmental factor which is required in addition, perhaps, to a constitutional predisposition. However, recognition of highrisk groups affords laboratory investigators an opportunity to study intensively the as yet unaffected sib, knowing that he is at high risk, and that the disease can be observed at earlier stages than usual as it occurs in the second child.
L. GORDIS (Sinai Hospital, Baltimore): Do you have information on radiation in utero to which these leukemia patients may have been exposed, since exposure to diagnostic radiography would be particularly likely in cases of twinning. Secondly, was there history of exposure of the mothers of these children to radiation before the time of conception? R.W.MILLER: We do not have such data of our own. We have been interested, of course, in data collected elsewhere, and note that recent reports concerning heavy radiation either preconception or in utero among persons in Hiroshima and Nagasaki has not yet demonstrated an increased risk of leukemia among either group. L.K. DIAMOND (Children's Hospital, Boston): Do twins have exactly the same type of leukemia and the same type of malignant cell.
The two pairs that we have observed each had the same type; in fact, the cells could be said to have come from the same individual when placed side by side. In both of these cases, by the time the first child was recognized and the second child was seen, a few weeks later, the signs of leukemic invasion had already occurred.
I also would like to know whether any of your sets of twins were mongols.
R.W. MILLER : Death certificates are not adequate for classifying leukemia by cell type. Your observations amplify those of our study in this regard.
None of the sets of twins had a death-certificate diagnosis of mongolism so we do not know the answer to that question. I did hear recently of a pair of twins, both mongols, one of whom developed leukemia two months ago, but the second is not as yet affected.
The interesting feature here is that this pair of twins is at high risk for two reasons: (1) mongols carry a risk of about one in 95 of developing leukemia before ten years of age, and (2) the twin, if identical, of a child with leukemia has a risk of about one in five of developing the disease.
K.W. DUMARS (University of California, Irvine): Have you had an opportunity to follow the parents of the children who died of leukemia? Are there any plans under way for making this possible in the death certificate mechanism?
R.W.MILLER: We have not, in this instance, and we have no plans. We have studied the situation the other way around, by determining the occurrence of leukemia in parents of children who had leukemia, and found no excess, and this negative observation has also been made by others. The parents of leukemic children in general are not more often leukemic than would be expected by chance. School of Med., State Univ. of New York at Buffalo, N.Y. Poliovirus antibody response in yG, yA and yM immunoglobulins in the serum, and nasal and duodenal secretions was studied in children following (1) live attenuated poliovaccine administered orally; (2) inactivated poliovaccine adminstered parenterally; (3) natural infection; or (4) high doses of inactivated poliovaccine administered intranasally. The techniques of radio-immunodiffusion and autoradiography using P 32 -labelled poliovirus were employed for demonstration of poliovirus antibody in the immunoglobulin classes. The pattern of response in the serum was remarkably similar following virus replication (live vaccine and natural infection) and inactivated vaccine administered parenterally. yM appeared initially and disappeared within 60 to 90 cays. yG appeared simultaneously with yM and subsequently comprised the bulk of persisting antibody. yA appeared most slowly and rose to modest titer. Most significantly, the secretory yA poliovirus antibody appeared regularly in nasal and duodenal secretions following oral immunization with live vaccine, but no antibody activity was detected in these secretions following parenteral immunization with inactivated vaccine. However, following intranasal inoculation of inactivated vaccine, secretory yA antibody appeared uniformly in nasal secretions, with little or no antibody response in the circulation. These observations provide a basis for explanation of the 'alimentary immunity' which has been shown to follow natural or induced infection with poliovirus. It is suggested that secretory yA antibody is a unique immunoglobulin system segregated from the systemic (serum) antibody system. Its implications may apply to any viral infection where the natural pathogenesis includes primary replication on mucosal surfaces. P. L. OGRA : Yes, we had an opportunity to study on a very limited scale the activity of 'transport piece'. Preliminary data suggest that biological activity against poliovirus is not associated with the isolated 'transport piece'. P. F. WEHRLE (LOS Angeles City General Hospital): What are Dr. OGRA'S thoughts concerning the relation of these studies to some of the earlier work with regard to poliovirus presence in the pharynx. As you recall, about 15 years ago, Dr. HOWARD HOWE was able to show in chimpanzees that elevated serum neutralizing antibody levels were associated with decreased virus carriage in the pharynx when animals were challenged with live virus.
We and others have shown a decrease in pharnygeal poliovirus carriage between those who had received inactivated poliomyelitis vaccine, in contrast to pharyngeal virus titers found in those household associates of cases who had not previously received inactivated vaccine.
P. L. OGRA : With our data indicating a similar antibody response in serum following immunization with live or inactivated vaccine, we do not feel that secretory antibody is a result of overflow of serum antibody into the secretions.
The limitation of implantation of virus following hyperimmunization with inactivated vaccine, as shown by Dr. HOWE, may be explained on the basis of overflow of the antigen. Adequate levels of the antigen probably reach the immunocompetent cells in the mucosa of the gut to induce a local secretory antibody response.
A. STEIGMAN (Mount Sinai School of Medicine, New York): I think the implications of this very elegant study must be clear to all who are interested in either the control of or understanding the pathogenesis of bacterial and viral infections. Certainly in terms of topical immunization in bacterial infections, such as cholera and typhoid, in which many attempts have been made to clarify the role of local enteric immunocompetent cells, the implications are clear.
In the early 1940's Dr. BELL was able to demonstrate neutralizing antibody to Lansing poliovirus in varying titers in the throat secretions of many individuals. At that time the only mode of such a study was in mice, and fractions of the immunoglobulins were not known.
Some ten or eleven years ago before this Society we we presented evidence in vitro of neutralizing coproantibodies to poliomyelitis in stool extracts. Presumably what we were demonstrating was what would today be termed IgA immunoglobulin.
I think a point of particular interest in the presentation this afternoon is the finding that nonreplicating antigens, if given in large enough doses intranasally, are capable of producing a local, if not a systemic, response to the specific antigen used.
H. L. HODES (Mount Sinai Hospital, New York): Perhaps the situation is not quite so simple, in the sense that conditions may be different in different organ systems. I think there is no doubt, from what you have shown, that there is local antibody production in the sense that you have described. However, in other organs the antibody can not be formed as a result of antigen on the surface of the organ.
For example, in breast milk the situation is different, in that here the antigen must get from some surface to the blood, and then to the breast. There are cells in the breast which make IgA antibody. We have shown that breast tissue, even of women 70 years of age, when put into tissue culture, can manufacture IgA globulin and specific IgA polio antibody.
Another indication of how complex this problem really is, I think, is shown by the work done in our laboratory on urinary excretion of various immunoglobulins. Dr. AINBENDER, Dr. BERGER and I have found that in urine there is excreted whole IgG specific polio antibody as well as IgG fragments. The interesting thing is that the IgG in the urine is the same as that in the serum, but the IgA polio antibody which is excreted in the urine is different from serum IgA polio antibody. It appears to be identical with colostral IgA polio antibody. This data was published in 'Nature' a few months ago.
I think, then, what might happen is that IgA antibody may be formed by local exposure of the cells in the areas that you speak of-but certainly there must be, as related to breast and urine, an overflow of this material or production of it in some other place in addition. Again we have to say that IgA antibody formation is more complicated than first meets the eye. P. L. OGRA : Yes, this is true. However, the uniqueness of 1 IS gamma A antibody and the data presented here would suggest that, with poliovirus, the synthesis of secretory antibody is local in the nasopharynx and alimentary tract.
H. L. HODES : I am sure it is at least local in the areas which you cite, Dr. OGRA. I do not question that at all.
In a paper that is now in press we report a difference in the serum immunoglobulin polio antibody in males as compared with females. This is not as evident in children as it is in adults. We had no infants in our study. Could you say something about the sex of the children in which you have shown the IgA antibody in the serum? P. L. OGRA : Yes, we did look; but we were unable to demonstrate any significant differences in serum gamma A response as related to the sex.
H.L.HODES: What ages were those children? P.L.OGRA: These children ranged from age two months to one year.
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The to calciferol has been seen in three children with refractory rickets. One showed phosphaturia, glucosuria, aminoaciduria and isosthenuria. The second had phosphaturia and aminoaciduria; the third showed only excessive phosphaturia. In all three patients, hyperchloremic acidosis (serum chloride above 110 mEq/1; serum bicarbonate less than 20 mEq/1) was present initially. The degree of respiratory compensation was variable, serum pH ranging from 7.20 to 7.38. Bone lesions healed promptly on calciferol (0.5 to 1.25 mg per day) supplemented in two instances with oral sodium phosphate. Serum chloride and bicarbonate returned to normal in all three patients without alkali supplementation. The sequence was repeated in one patient who relapsed after inadvertent interruption of therapy. Aminoaciduria decreased and glucosuria disappeared. These findings corroborate previous reports implicating calciferol in renal tubular bicarbonate transport. The possibility that glucose, phosphate, and bicarbonate may to some extent share a common transport system is suggested by the present results. Other investigators have drawn similar inferences from animal data. Alkali therapy may be unnecessary in the management of refractory rickets associated with multiple tubular dysfunction; a trial of calciferol alone is clearly desirable. I feel there is another variation of this disease, namely the patient has the same physical and laboratory changes, but whose phosphorous does not rise with calciferol. A number of these patients have been reported.
In these cases possibly calciferol affects the tubules to a lesser degree or plays an additional role altogether.
W.H.BERGSTROM: I think that the response in tubular phosphate transport is quite variable. One would not have to conclude there were two sorts of patients, but perhaps a spectrum of severity.
The last of these three patients whom we showed required oral phosphate supplementation in addition to calciferol. It was not otherwise possible to get his serum phosphate up to normal, and this, I would agree, is true of most children with refractory rickets. Very few achieve what, for their age, is an appropriate serum phosphate concentration. K. A. BRADFORD (New York Hospital): In all three of your patients were the serum tyrosine levels all perfectly normal? Tyrosemia can present as refractory rickets of unknown etiology, and should be added to the differential diagnosis of this condition.
W. H. BERGSTROM : The serum tyrosine level was normal in the first patient shown, and was not measured in the others.
The others have done so well on. calciferol that it does not seem likely that they had tyrosinemia.
H. RIKKERS (University of Wisconsin, Medical School): A number of investigators have reported that the treatment of the acidosis in these cases actually diminishes the amount of vitamin D required to effect healing. In view of the small therapeutic margin of safety of vitamin D, would it not be wise to treat these patients with both calciferol, and sodium and potassium citrate?
W W. H. BERGSTROM : The percent of tubular reabsorbed phosphate did increase with treatment. It has always been debatable to what extent the improvement in either simple or refractory rickets following calciferol might be due to cessation of secondary hyperparathyroidism. This seems a very hard point to clarify in the absence of good quantitative methods for parathyroid hormone. One might, indeed, argue that the results shown here were all due to parathyroid suppression, and that the calciferol effect was entirely that of enhancing intestinal calcium transport, which is, after all, the most generally recognized action of calciferol itself.
It is hard to believe that quite this many derangements in tubular function could be due to secondary hyperparathyroidism. Phosphaturia and aminoaciduria are the ones for which the evidence you have cited has been given, but glucosuria and diminished bicarbonate transport have not been consistent findings in either clinical or experimental hyperparathyroidism. Neither has potassium wasting, which has been seen in some patients with Fanconi's syndrome. To relate all of these to secondary hyperparathyroidism seems, in my opinion, to be stretching the role of the parathyroid.
A.B. HAYLES (Mayo Clinic, Rochester): The two patients reported before this group in 1955 have remained in relatively good health. Both have graduated from college. One, the girl, is now married. She attained a height of 58". Due to a gradual reduction of Ccr to 45 ml/min/1.73 m 2 with elevation of serum creatinine to 2 mg % vitamin D with and without alkali were discontinued on several occasions but serum alkaline phosphatase increased and bone pain returned. The patient has had a chronic urinary tract infection the past 5 years.
The boy attained a height of 61" and also has experienced a reduction of glomerular function. Serum creatinine has increased to 2.4 mg %. Vitamin D has been withdrawn at times but rising levels of serum alkaline phosphatase and pelvic pain has forced us to restart vitamin D. Alkali and potassium were not stopped when the vitamin D was discontinued.
H. E. HARRISON (Baltimore): I may say that the argument about the role of calciferol on renal tubular function has gone on for about twenty years now, and it still is not solved. I think Dr. BERGSTROM'S paper nicely points out some of the complexities in this problem.
For example, patient 2 had a serum calcium of 6.8. The assumption is that this patient probably did have secondary hyperparathyroidism, and yet was refractory to parathyroid function as far as bone calcium mobilization was concerned, and was unable to raise the serum calcium.
The question is: Would that excess parathyroid hormone be able to produce an effect on renal tubular function? Here again there are arguments. Actually, I am rather partial to the explanation which Dr. BERG-STROM gave near the end of his paper, in which he suggests that perhaps there are changes in the membrane of the proximal renal tubule, not only, as a result of calcium deficiency but perhaps phosphate deficiency as well.
For example, these patients do have chronic phosphate depletion, and there may be a whole host of changes in proximal tubular function as a result of both calcium and phosphate depletion of the cells, which are very difficult to study by gross measurements of renal clearances. This is emphasized, as suggested by one of the other discussers, by the fact that in renal tubular acidosis one can increase TRP simply by correcting the acidosis.
In other words, we have multiple interrelated effects, and how calciferol plays its moderating role in this interrelation remains somewhat of a puzzle. However, these cases do again present the interesting possibility that we are dealing with a direct effect of a sterol on membrane permeability. CHAPMAN*, Univ. of Minnesota, Minneapolis. Previous studies suggest that anti-streptolysin O (ASO) levels in patients with streptococcal pyoderma are not significantly higher than in normal controls. The reliability of this finding is not certain since it results from comparison of single titers rather than rises in titer. If valid, it is not clear whether this observation is due to a general immunological unresponsiveness to such infections, or to differences in strains infecting the skin, or to a lack of response to this particular antigen following infections limited to this site.
In the present study, paired sera obtained from 57 children during an epidemic of nephritis showed both an ASO and an anti-desoxyribonuclease B (antiDNAse B) response when group A streptococci were isolated from both skin lesions and the upper respiratory tract, or from the latter site alone. In contrast, patients with streptococci isolated only from the skin showed a significant rise (p<0.05) in the anti-DNAse B titer but not in the ASO titer. This difference was obtained even when the strain infecting the different sites was the same (type 49). On the other hand, antibody responses to streptococcal nicotinamideadenine-dinucleotidase (NADase) appeared to be strain related. Antibody titers for all three streptococcal antigens tended to be higher in children who developed nephritis than in those who did not.
These data indicate that group A streptococci are antigenic when present in skin lesions alone but produce a different host response than that resulting from pharyngeal infection with the same strain. Since certain lipids are known to be potent inhibitors of the hemolytic capacity of streptolysin O, the possibility that skin lipids may modify its antigenicity presents one possible explanation for this disparity. I have followed a number of children with nephritis and impetigo in Trinidad. We have had sera sent back to my laboratory for serial antibody studies of streptococcal antibodies. We were struck by the low incidence of elevated antistreptolysin O in children with impetigo and nephritis in Trinidad.
At first we thought this might be an epidemiological difference in children seen in Trinidad, but, as is the custom in our laboratory when we fail to get a response to antistreptolysin O, we run other streptococcal antibodies, and we found a number of patients, about 85 percent of our nephritic children in Trinidad, who had a significant rise in antihyaluronidase antibody.
So I would like to compliment the authors on explaining why we got a rise in antihyaluronidase and not in antistreptolysin O.
H. C. DILLON (University of Alabama): For the past several years we have been comparing antibody titers to streptolysin O and DNAse B in children with acute glomerulonephritis, most of whom have skin infections. There has been a striking difference in response to these two antigens, the mean titer of ASLO being 250 compared with a mean anti-DNAse B titer of 1250.
This was an unexpected difference in light of earlier studies of nephritis associated with respiratory disease. In our own population relatively few children with nephritis following respiratory infection have been seen; however, antistreptolysin O titers were generally higher in those patients. In a large group of children with impetigo but without evidence of nephritis the mean anti-DNAse B titers were still above normal but the mean titer was a half log (0.5 log) lower than that for nephritics and the ASLO titers were within normal range.
Whether or not these differences in antibody titers are related to streptococcal sera types is not yet certain; however, the two prevalant sera types associated with skin infection and nephritis (M-2 and M-49) and the strains from children with uncomplicated impetigo (agglutination types 3/13/B3264) are relatively infrequently found in children with pharyngitis in our population.
In experimental animal studies we found that these skin strains do elicit significant anti-DNAse B responses but relatively low anti-streptolysin O responses.
The fact that the children we see with skin infection have striking regional lymphadenopathy raises the question in my mind as to the importance of skin lipid inhibition of the streptolysin O response. DEJANI'S studies of cervical lymphadenitis indicated that streptococci could be isolated from lymph nodes. We occasionally recover streptococci from those of children with impetigo. The possibility that replication of streptococci within lymph nodes, with relatively little lipid present there to inhibit streptolysin O, might further support the idea that antibody differences are not the result of interference of streptolysin O at the skin lesion site but are related to the strain of infecting strepto- (DNA) has been under investigation in our laboratory as a model for this purpose. 'Competence', or the ability to take up and be transformed by DNA, changes with the physiologic state during growth and can be controlled. This paper describes the electron microscopic differences between the interaction of transforming DNA and H. influenzae cells prepared for high 'competence' and the same population in the low or 'incompetent' state. Examination of platinum shadowed specimens revealed that in both competent and incompetent populations, the first event seen 5 seconds after the interaction with transforming DNA is attachment of DNA strands to the cell surface. The morphology of attachment is characteristic and does not differ in biologically competent and noncompetent populations. Competent cells show attachment of an average of 7.6 strands to virtually all cells in 5 seconds (99 % of 100 cells studied in each of 4 different experiments). Incompetent cells show great variation in different experiments in the degree of attachment at 5 seconds; in 6 experiments, the attachment varied from 25 % to 87 % of cells with an average of 3.9 strands per cell. A significant difference between competent and incompetent cells was seen after exposure to DNA for 5 minutes. Competent populations showed a decrease in the frequency of cells with attached DNA strands and the average number of strands per cell; incompetent cells exhibited an increase in each of these phenomena. The observations suggest that insusceptibility of incompetent cells is not caused by failure of adsorption of DNA but by inability to perform a necessary metabolic reaction. Sites capable of adsorbing DNA are present in both competent and incompetent bacteria. Discussion H.E.ALEXANDER (College of Physicians and Surgeons, Columbia Univ.): Even though the application of electron microscopy to microbial genetics, so beautifully demonstrated by Dr. STACHURA, is in its infancy, it clearly offers a new dimension in future explorations, and raises a number of challenging questions.
That the development of competence is dependent on protein synthesis is now well established. A theory has evolved that formation of specific protein sites, capable of binding deoxyribonucleic acid (DNA) is essential for emergence of competence. Electron microscopic study showed that adsorption of DNA takes place in both competent and incompetent bacteria] populations but biological tests revealed that the latter are not transformed.
Dr. STACHURA demonstrated characteristic morphologic patterns occurring at the sites of adsorption of DNA. It would be very interesting to find out if the morphology of attachment is a special quality of the DNA preparations used. Perhaps Dr. STACHURA would like to comment upon that.
I.STACHURA: Although several bacterial species have been transformed, search for transformable strains is conducted blindly. The process of transformation itself and the nature of competence are far from being clear.
Our report attempts to supplement knowledge gained by bacteriologic and biochemical methods through morphologic studies. Two types of DNA fixation by competent cells are known. One is reversible and preliminary to the second, which is irreversible. Our studies show that incompetent cells can fix DNA. This fixation may be reversible only; incompetent cells would therefore be incapable of irreversible attachment or fixation of DNA.
Experience gained from biological experiments started in 1950 when ALEXANDER and LEIDY demonstrated transformation ofH. influenzae has been utilized and the same method of preparation of highly active transforming DNA has been used. DNA prepared in this manner contains some impurities (RNA, protein and possibly polysaccharides), which may affect the morphology of our DNA preparations and the morphology of the attachment of DNA to bacteria.
Electron microscopic studies on the attachment of highly purified DNA to bacterial cells will be undertaken.
